Filament Health Shares Q1 2023 Financials, Material Uncertainties Upon Securing Additional Financing - Filament Health (OTC:FLHLF), Jupiter Acquisition (NASDAQ:JAQC)

Natural psychedelic drug development company Filament Health (OTCQB: FLHLF) has released its unaudited consolidated, condensed financial results for Q1 2023 ended June 30. Numbers show:

Related Keywords

Nagoya ,Aichi ,Japan ,Gabon ,Benjamin Lightburn ,Translational Psychedelic Research Program ,Jupiter Acquisition Corp ,University Of Washington ,Neolumina Bioscience Inc ,Nasdaq ,Jupiter Acquisition ,Cognitive Behavioral Therapy ,Neolumina Bioscience ,Nagoya Protocol Compliant ,